<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.drugs.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="0.91">
<channel>
	<title>Drugs.com - FDA MedWatch Alerts</title>
	<link>http://www.drugs.com/fda_alerts.html</link>
	<description>Latest alerts to consumers and health care providers warning of recently identified adverse effects associated with currently available drugs and supplements.</description>
	<language>en</language>

	<image><link>http://www.drugs.com/</link><url>http://www.drugs.com/img/drugscom-feedburner.gif</url><title>Drugs.com</title></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.drugs.com/Drugscom-FdaMedwatchAlerts" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item>
		<title>Propoxyphene-containing Products</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/RV5EgiWYQEY/propoxyphene-containing-products-12554.html</link>
		<description>Audience: Pharmacists, pain management healthcare professionals  
FDA notified healthcare professionals that it is taking several actions to reduce the risk of overdose in patients using pain medications that contain propoxyphene because of data...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/JkkVfIvhGeWJGZActRYE-CMlAxw/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JkkVfIvhGeWJGZActRYE-CMlAxw/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/JkkVfIvhGeWJGZActRYE-CMlAxw/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JkkVfIvhGeWJGZActRYE-CMlAxw/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/RV5EgiWYQEY" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 07 Jul 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/propoxyphene-containing-products-12554.html</feedburner:origLink></item>

	<item>
		<title>Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/-LkA_4h3aLQ/varenicline-marketed-chantix-bupropion-marketed-zyban-wellbutrin-generics-12552.html</link>
		<description>Audience: Neuropsychiatric healthcare professionals, patients  
FDA notified healthcare professionals and patients that it has required the manufacturers of the smoking cessation aids varenicline (Chantix) and bupropion (Zyban and generics) to add...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/h91S5J1wdcqjPhZsdj_s8i91ozI/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/h91S5J1wdcqjPhZsdj_s8i91ozI/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/h91S5J1wdcqjPhZsdj_s8i91ozI/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/h91S5J1wdcqjPhZsdj_s8i91ozI/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/-LkA_4h3aLQ" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 01 Jul 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/varenicline-marketed-chantix-bupropion-marketed-zyban-wellbutrin-generics-12552.html</feedburner:origLink></item>

	<item>
		<title>Lantus (insulin glargine)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/9DdPf4uzzIQ/lantus-insulin-glargine-12551.html</link>
		<description>Audience: Diabetes healthcare professionals, patients FDA notified healthcare professionals and patients that it is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible risk for...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/g2k7xdSAgZeIvF6WTQmC0FiUBuE/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/g2k7xdSAgZeIvF6WTQmC0FiUBuE/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/g2k7xdSAgZeIvF6WTQmC0FiUBuE/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/g2k7xdSAgZeIvF6WTQmC0FiUBuE/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/9DdPf4uzzIQ" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 01 Jul 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/lantus-insulin-glargine-12551.html</feedburner:origLink></item>

	<item>
		<title>Nestle Toll House Prepackaged, Refrigerated Cookie Dough</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/Ei4tdta3T_4/nestle-toll-house-prepackaged-refrigerated-cookie-dough-12540.html</link>
		<description>Audience: Consumers, All Healthcare Professionals FDA and the CDC are warning consumers not to eat any varieties of prepackaged Nestle Toll House refrigerated cookie dough due to the risk of contamination with E. coli O157:H7 (a bacterium that...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/zZZv-RYtcVnK1_jmQqRVhzPObXQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/zZZv-RYtcVnK1_jmQqRVhzPObXQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/zZZv-RYtcVnK1_jmQqRVhzPObXQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/zZZv-RYtcVnK1_jmQqRVhzPObXQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/Ei4tdta3T_4" height="1" width="1"/&gt;</description>
		<pubDate>Sat, 20 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/nestle-toll-house-prepackaged-refrigerated-cookie-dough-12540.html</feedburner:origLink></item>

	<item>
		<title>Stamina-Rx Dietary Supplement Products</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/1ik7H1th5Qc/stamina-rx-dietary-supplement-products-12538.html</link>
		<description>Audience: Consumers FDA and Hi-Tech Pharmaceuticals notified patients and healthcare professionals of a nationwide recall of all product sold under the name Stamina-Rx. FDA lab analysis found that the product contained the undeclared ingredient -...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/KftVZg2tcMIrgpX1NqgFz-j3dZM/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/KftVZg2tcMIrgpX1NqgFz-j3dZM/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/KftVZg2tcMIrgpX1NqgFz-j3dZM/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/KftVZg2tcMIrgpX1NqgFz-j3dZM/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/1ik7H1th5Qc" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 19 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/stamina-rx-dietary-supplement-products-12538.html</feedburner:origLink></item>

	<item>
		<title>Cefepime (marketed as Maxipime) Update of Ongoing Safety Review</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/3p8PJrs9Q4M/cefepime-marketed-maxipime-update-ongoing-safety-review-12537.html</link>
		<description>Audience: Infectious disease healthcare professionals  
FDA notified healthcare professionals that it has finished its analysis of a possible risk of higher death with cefepime, an antibiotic, following publication of a study that suggested a...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/v9mz49QPWRxGqL8FCnkte79CBSA/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/v9mz49QPWRxGqL8FCnkte79CBSA/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/v9mz49QPWRxGqL8FCnkte79CBSA/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/v9mz49QPWRxGqL8FCnkte79CBSA/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/3p8PJrs9Q4M" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 17 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/cefepime-marketed-maxipime-update-ongoing-safety-review-12537.html</feedburner:origLink></item>

	<item>
		<title>Zicam Cold Remedy Nasal Products (Cold Remedy Nasal Gel, Cold Remedy Nasal Swabs, and  Cold Remedy Swabs, Kids Size)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/9V2GRGFg5RQ/zicam-cold-remedy-nasal-products-cold-remedy-nasal-gel-cold-remedy-nasal-swabs-cold-remedy-swabs-12536.html</link>
		<description>Audience: Consumers FDA notified consumers and healthcare professionals to discontinue use of three Zicam Nasal Gel/Nasal Swab products sold over-the-counter as cold remedies because they are associated with the loss of sense of smell that may be...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/4k6lBHBR-pDx3nbz_C1NdqDY5GI/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/4k6lBHBR-pDx3nbz_C1NdqDY5GI/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/4k6lBHBR-pDx3nbz_C1NdqDY5GI/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/4k6lBHBR-pDx3nbz_C1NdqDY5GI/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/9V2GRGFg5RQ" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 16 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/zicam-cold-remedy-nasal-products-cold-remedy-nasal-gel-cold-remedy-nasal-swabs-cold-remedy-swabs-12536.html</feedburner:origLink></item>

	<item>
		<title>Medtronic Kappa Series 600/700/900, Sigma Series 100/200/300 Pacemakers</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/Y1n3gSJ1mAU/medtronic-kappa-series-600-700-900-sigma-series-100-200-300-pacemakers-12541.html</link>
		<description>Audience: Cardiology healthcare professionals 
[Posted 06/11/2009] Medtronic and FDA notified healthcare professionals and patients of a Class I recall of Medtronic Kappa Series 600/700/900 and Sigma Series 100/200/300 pacemakers due to a failure of...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/MCzk5CfBI1mYkDZYlMS7clYYhz0/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/MCzk5CfBI1mYkDZYlMS7clYYhz0/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/MCzk5CfBI1mYkDZYlMS7clYYhz0/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/MCzk5CfBI1mYkDZYlMS7clYYhz0/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/Y1n3gSJ1mAU" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 15 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/medtronic-kappa-series-600-700-900-sigma-series-100-200-300-pacemakers-12541.html</feedburner:origLink></item>

	<item>
		<title>Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder - Communication about an Ongoing Safety Review</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/xt26zhjFUsk/stimulant-children-attention-deficit-hyperactivity-disorder-communication-ongoing-safety-review-12535.html</link>
		<description>Audience: Pediatricians, Neuropsychiatric healthcare professionals  
Products involved include: Focalin, Focalin XR (dexmethylphenidate HCl ); Dexedrine, Dexedrine Spansules, Dextroamphetamine ER, Dextrostat (dextroamphetamine sulfate); Vyvanse...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/wNwK6B6x41G6OS2JRipwB9VTFbQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/wNwK6B6x41G6OS2JRipwB9VTFbQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/wNwK6B6x41G6OS2JRipwB9VTFbQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/wNwK6B6x41G6OS2JRipwB9VTFbQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/xt26zhjFUsk" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 15 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/stimulant-children-attention-deficit-hyperactivity-disorder-communication-ongoing-safety-review-12535.html</feedburner:origLink></item>

	<item>
		<title>Levemir Insulin (Novo Nordisk)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/xyVlaT1ipSo/levemir-insulin-novo-nordisk-12534.html</link>
		<description>Audience: Patients, pharmacists, diabetes healthcare professionals  
FDA notified patients and healthcare professionals that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. are being sold in the U.S. market, may not...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/xLlE3-slhJJsxbnx_mHHUl7iKRQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/xLlE3-slhJJsxbnx_mHHUl7iKRQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/xLlE3-slhJJsxbnx_mHHUl7iKRQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/xLlE3-slhJJsxbnx_mHHUl7iKRQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/xyVlaT1ipSo" height="1" width="1"/&gt;</description>
		<pubDate>Sat, 13 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/levemir-insulin-novo-nordisk-12534.html</feedburner:origLink></item>

	<item>
		<title>Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/1MVGtLOpa8k/leukotriene-inhibitors-montelukast-marketed-singulair-zafirlukast-marketed-accolate-zileuton-12533.html</link>
		<description>Audience: Pulmonology healthcare professionals FDA provided healthcare professionals with updated information on the original March 2008 early communication and January 2009 follow-up communication about the ongoing safety review for the leukotriene...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/8VMeem_dTAEnVPeu6hGDwzCNVqM/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/8VMeem_dTAEnVPeu6hGDwzCNVqM/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/8VMeem_dTAEnVPeu6hGDwzCNVqM/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/8VMeem_dTAEnVPeu6hGDwzCNVqM/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/1MVGtLOpa8k" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 12 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/leukotriene-inhibitors-montelukast-marketed-singulair-zafirlukast-marketed-accolate-zileuton-12533.html</feedburner:origLink></item>

	<item>
		<title>Sirolimus (marketed as Rapamune)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/ifkBNBOAWsw/sirolimus-marketed-rapamune-12532.html</link>
		<description>Audience: Transplantation healthcare professionals  
FDA notified healthcare professionals of clinical trial data that suggest increased mortality in stable liver transplant patients after conversion from a calcineurin inhibitor (CNI)-based...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/0dKTBRTIIUTpw2fjs6QV4cUS084/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/0dKTBRTIIUTpw2fjs6QV4cUS084/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/0dKTBRTIIUTpw2fjs6QV4cUS084/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/0dKTBRTIIUTpw2fjs6QV4cUS084/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/ifkBNBOAWsw" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 11 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/sirolimus-marketed-rapamune-12532.html</feedburner:origLink></item>

	<item>
		<title>Skin Products Made by Clarcon</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/wpcnmLrghWI/skin-products-made-clarcon-12530.html</link>
		<description>Audience: Consumers, pharmacists, all healthcare professionals FDA notified consumers and healthcare professionals that Clarcon Biological Chemistry Laboratory is recalling some skin sanitizers and skin protectants because of high levels of...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/JLR-QwzcfR6yAzgzr-0XIp-zcEM/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JLR-QwzcfR6yAzgzr-0XIp-zcEM/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/JLR-QwzcfR6yAzgzr-0XIp-zcEM/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JLR-QwzcfR6yAzgzr-0XIp-zcEM/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/wpcnmLrghWI" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 09 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/skin-products-made-clarcon-12530.html</feedburner:origLink></item>

	<item>
		<title>Propylthiouracil</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/EmCjnpMb7wI/propylthiouracil-12528.html</link>
		<description>Audience: Endocrine healthcare professionals, Pharmacists, Pediatricians FDA notified healthcare professionals of the risk of serious liver injury, including liver failure and death, with the use of propylthiouracil in adult and pediatric patients....
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/XKAJmbtn_QcKABSRWL0MQnNNB7k/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XKAJmbtn_QcKABSRWL0MQnNNB7k/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/XKAJmbtn_QcKABSRWL0MQnNNB7k/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XKAJmbtn_QcKABSRWL0MQnNNB7k/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/EmCjnpMb7wI" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 03 Jun 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/propylthiouracil-12528.html</feedburner:origLink></item>

	<item>
		<title>Simponi (golimumab)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/R9PejTR6BiQ/simponi-golimumab-12542.html</link>
		<description>Audience: Rheumatological healthcare professionals
[Posted 05/27/2009] Centocor Ortho Biotech and FDA reminded healthcare professionals of the risk of serious fungal infections associated with TNF-&amp;Icirc;&amp;plusmn; blockers, including Simponi...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/k9R32b6k8z8M7H3XgxmdML_jahQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/k9R32b6k8z8M7H3XgxmdML_jahQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/k9R32b6k8z8M7H3XgxmdML_jahQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/k9R32b6k8z8M7H3XgxmdML_jahQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/R9PejTR6BiQ" height="1" width="1"/&gt;</description>
		<pubDate>Sat, 30 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/simponi-golimumab-12542.html</feedburner:origLink></item>

	<item>
		<title>Digoxin, USP 0.125 mg, Digoxin, USP 0.25 mg (Caraco brand)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/0g5IbaBUGOA/digoxin-usp-0-125-mg-digoxin-usp-0-25-mg-caraco-brand-12543.html</link>
		<description>Audience: Pharmacists, cardiology healthcare professionals, consumers
[UPDATED 05/12/2009] AS Medication Solutions, LLC, a drug repackage company, announced today that all tablets of Caraco brand Digoxin, USP, 0.25 mg, distributed prior to March 31,...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/6iBr6uvdCCT5wp2EUG2HfW3wlqo/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/6iBr6uvdCCT5wp2EUG2HfW3wlqo/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/6iBr6uvdCCT5wp2EUG2HfW3wlqo/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/6iBr6uvdCCT5wp2EUG2HfW3wlqo/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/0g5IbaBUGOA" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 29 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/digoxin-usp-0-125-mg-digoxin-usp-0-25-mg-caraco-brand-12543.html</feedburner:origLink></item>

	<item>
		<title>Testosterone gel products (AndroGel 1% and Testim 1% )</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/2Da1Wroe7yk/testosterone-gel-products-androgel-1-37-testim-1-37-12547.html</link>
		<description>Audience: Urological and Endocrinological healthcare professionals, pediatricians&amp;nbsp;
[Posted 05/07/2009] FDA notified healthcare professionals that it will require two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/TzsTZqpMbG-eWEq_Zmr-tTitnck/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/TzsTZqpMbG-eWEq_Zmr-tTitnck/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/TzsTZqpMbG-eWEq_Zmr-tTitnck/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/TzsTZqpMbG-eWEq_Zmr-tTitnck/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/2Da1Wroe7yk" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 28 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/testosterone-gel-products-androgel-1-37-testim-1-37-12547.html</feedburner:origLink></item>

	<item>
		<title>Biosite brand Triage Cardiac Panel</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/dICogGN1cgs/biosite-brand-triage-cardiac-panel-12546.html</link>
		<description>Audience: Emergency care managers, hospital risk managers, laboratory services managers
[Posted 05/08/2009] Biosite and FDA notified healthcare professionals of the Class 1 recall of the Biosite brand Triage Cardiac Panel, a test is used by health...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/jC6FDQif6m7y4oatYP4MA38Iutg/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/jC6FDQif6m7y4oatYP4MA38Iutg/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/jC6FDQif6m7y4oatYP4MA38Iutg/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/jC6FDQif6m7y4oatYP4MA38Iutg/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/dICogGN1cgs" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 28 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/biosite-brand-triage-cardiac-panel-12546.html</feedburner:origLink></item>

	<item>
		<title>Tarceva (erlotinib) May 2009</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/X_xMn0we97E/tarceva-erlotinib-may-2009-12545.html</link>
		<description>Audience: Oncological, dermatological and ophthalmological healthcare professionals&amp;nbsp;
[Posted 05/08/2009] OSI, Genentech and FDA notified healthcare professionals of new safety information added to the WARNINGS AND PRECAUTIONS sections of the...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/EMOoYnN7ov90xGkoYoChzJLcyC0/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/EMOoYnN7ov90xGkoYoChzJLcyC0/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/EMOoYnN7ov90xGkoYoChzJLcyC0/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/EMOoYnN7ov90xGkoYoChzJLcyC0/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/X_xMn0we97E" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 28 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/tarceva-erlotinib-may-2009-12545.html</feedburner:origLink></item>

	<item>
		<title>Fun Express Water-based Face Paints for Children</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/5Cf4Y77AzE8/fun-express-water-based-face-paints-children-12544.html</link>
		<description>Audience: Consumers, Pediatricians, Dermatologists
[UPDATED 05/26/2009] Fun Express expanded its recall of face paint items to include two additional face paint colors, 85/2338 (White face paint) and 85/2339 (Yellow face paint) The products were...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/Bf8yOeSIlw5vj05-9KIqOZvuR-4/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Bf8yOeSIlw5vj05-9KIqOZvuR-4/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/Bf8yOeSIlw5vj05-9KIqOZvuR-4/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Bf8yOeSIlw5vj05-9KIqOZvuR-4/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/5Cf4Y77AzE8" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 28 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/fun-express-water-based-face-paints-children-12544.html</feedburner:origLink></item>

	<item>
		<title>Simponi (golimumab)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/9mgXobRsP8c/simponi-golimumab-12523.html</link>
		<description>Audience: Rheumatological healthcare professionals Centocor Ortho Biotech and FDA reminded healthcare professionals of the risk of serious fungal infections associated with TNF-&amp;alpha; blockers, including Simponi [golimumab]. FDA has reported that...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/fGdFUkC89NqEgHK7FLXvtxcGBOc/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/fGdFUkC89NqEgHK7FLXvtxcGBOc/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/fGdFUkC89NqEgHK7FLXvtxcGBOc/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/fGdFUkC89NqEgHK7FLXvtxcGBOc/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/9mgXobRsP8c" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 28 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/simponi-golimumab-12523.html</feedburner:origLink></item>

	<item>
		<title>Fun Express Water-based Face Paints for Children</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/r-pyimFA2Dc/fun-express-water-based-face-paints-children-12522.html</link>
		<description>Audience: Consumers, Pediatricians, Dermatologists Fun Express expanded its recall of face paint items to include two additional face paint colors, 85/2338 (White face paint) and 85/2339 (Yellow face paint) The products were distributed primarily to...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/6YW1wFkj6n6t9PASDCus6FszuM0/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/6YW1wFkj6n6t9PASDCus6FszuM0/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/6YW1wFkj6n6t9PASDCus6FszuM0/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/6YW1wFkj6n6t9PASDCus6FszuM0/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/r-pyimFA2Dc" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 26 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/fun-express-water-based-face-paints-children-12522.html</feedburner:origLink></item>

	<item>
		<title>Antiepileptic Drugs</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/gVHiaFBSgXw/antiepileptic-drugs-12548.html</link>
		<description>Audience: Neuropsychiatric healthcare professionals, other healthcare professionals, patients
[UPDATE 05/05/2009] FDA notified healthcare professionals that it approved updated labeling for antiepileptic drugs used to treat epilepsy, psychiatric...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/bRlFI2ZFskOTO_xEzb213YG8tQQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/bRlFI2ZFskOTO_xEzb213YG8tQQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/bRlFI2ZFskOTO_xEzb213YG8tQQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/bRlFI2ZFskOTO_xEzb213YG8tQQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/gVHiaFBSgXw" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 18 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/antiepileptic-drugs-12548.html</feedburner:origLink></item>

	<item>
		<title>Fun Express Water-based Face Paints for Children</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/30fJuUWQ6l4/fun-express-water-based-face-paints-children-12520.html</link>
		<description>Audience: Consumers, Pediatricians, Dermatologists FDA is notifying consumers and healthcare professionals of the recall of cosmetic &amp;quot;Face Paint&amp;quot; items labeled as distributed by Oriental Trading Co., Omaha, Neb., due to adverse event...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/UZQYvTkg2RHzw2lQLFZvZKlfk0k/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/UZQYvTkg2RHzw2lQLFZvZKlfk0k/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/UZQYvTkg2RHzw2lQLFZvZKlfk0k/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/UZQYvTkg2RHzw2lQLFZvZKlfk0k/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/30fJuUWQ6l4" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 12 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/fun-express-water-based-face-paints-children-12520.html</feedburner:origLink></item>

	<item>
		<title>Digoxin, USP 0.25 mg</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/lzxDc615xPo/digoxin-usp-0-25-mg-12519.html</link>
		<description>Audience: Pharmacists, cardiology healthcare professionals, consumers AS Medication Solutions, LLC, a drug repackage company, announced today that all tablets of Caraco brand Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/-udo-J3WmnzJA-XeRgzARe_kYfk/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/-udo-J3WmnzJA-XeRgzARe_kYfk/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/-udo-J3WmnzJA-XeRgzARe_kYfk/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/-udo-J3WmnzJA-XeRgzARe_kYfk/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/lzxDc615xPo" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 12 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/digoxin-usp-0-25-mg-12519.html</feedburner:origLink></item>

	<item>
		<title>Influend Cough and Cold Products</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/J3yTblvDYy8/influend-cough-cold-products-12550.html</link>
		<description>Audience: Pharmacists, consumers
[Posted 04/16/2009] ION Labs and FDA notified consumers and healthcare professionals of the recall of all Influend Cough and Cold products sold on or after May 30, 2008 due to the possibility that the products may be...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/uzbY0X6kn12dujd6yPmRB51YRmg/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/uzbY0X6kn12dujd6yPmRB51YRmg/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/uzbY0X6kn12dujd6yPmRB51YRmg/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/uzbY0X6kn12dujd6yPmRB51YRmg/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/J3yTblvDYy8" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 11 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/influend-cough-cold-products-12550.html</feedburner:origLink></item>

	<item>
		<title>Dietary Supplements Distributed by Universal ABC Beauty Supply International, Inc.</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/QOsqTPmriP8/dietary-supplements-distributed-universal-abc-beauty-supply-international-inc-12549.html</link>
		<description>Audience: Consumers, pharmacists
[Posted 04/22/2009] ABC Beauty Supply and FDA notified consumers and healthcare professionals of a recall of 34 dietary supplement products. FDA lab analyses identified undeclared sibutramine, an FDA-approved drug,...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/AtSwFRA5CsTngp3tzk-_W-VBA0U/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/AtSwFRA5CsTngp3tzk-_W-VBA0U/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/AtSwFRA5CsTngp3tzk-_W-VBA0U/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/AtSwFRA5CsTngp3tzk-_W-VBA0U/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/QOsqTPmriP8" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 11 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/dietary-supplements-distributed-universal-abc-beauty-supply-international-inc-12549.html</feedburner:origLink></item>

	<item>
		<title>Tarceva (erlotinib)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/8oo-cwmmiiU/tarceva-erlotinib-12517.html</link>
		<description>Audience: Oncological, dermatological and ophthalmological healthcare professionals OSI, Genentech and FDA notified healthcare professionals of new safety information added to the WARNINGS AND PRECAUTIONS sections of the prescribing information for...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/_6fLp3BFX5NZjMU0gDk4HjeDsTA/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/_6fLp3BFX5NZjMU0gDk4HjeDsTA/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/_6fLp3BFX5NZjMU0gDk4HjeDsTA/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/_6fLp3BFX5NZjMU0gDk4HjeDsTA/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/8oo-cwmmiiU" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 08 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/tarceva-erlotinib-12517.html</feedburner:origLink></item>

	<item>
		<title>Testosterone gel products (AndroGel and Testim)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/QxKayL_I314/testosterone-gel-products-androgel-testim-12516.html</link>
		<description>Audience: Urological and Endocrinological healthcare professionals, pediatricians FDA notified healthcare professionals that it will require two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/_PJIbKwF4EpLvqdv9aJiVGjESiw/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/_PJIbKwF4EpLvqdv9aJiVGjESiw/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/_PJIbKwF4EpLvqdv9aJiVGjESiw/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/_PJIbKwF4EpLvqdv9aJiVGjESiw/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/QxKayL_I314" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 07 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/testosterone-gel-products-androgel-testim-12516.html</feedburner:origLink></item>

	<item>
		<title>Antiepileptic Drugs</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/MqnHdLSzBbQ/antiepileptic-drugs-12333.html</link>
		<description>Audience: Neuropsychiatric healthcare professionals, other healthcare professionals, patients [UPDATE 05/05/2009] FDA notified healthcare professionals that it approved updated labeling for antiepileptic drugs used to treat epilepsy, psychiatric...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/OilDlf915sAldm_mhAPX6AhJFBE/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/OilDlf915sAldm_mhAPX6AhJFBE/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/OilDlf915sAldm_mhAPX6AhJFBE/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/OilDlf915sAldm_mhAPX6AhJFBE/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/MqnHdLSzBbQ" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 05 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/antiepileptic-drugs-12333.html</feedburner:origLink></item>

	<item>
		<title>Disetronic Medical Systems Inc. ACCU-CHEK Spirit Insulin Pump</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/vOdMgG-L1Yo/disetronic-medical-systems-inc-accu-chek-spirit-insulin-pump-12515.html</link>
		<description>Audience: Diabetes healthcare professionals, patients Disetronic Medical Systems Inc. and FDA notified healthcare professionals about a defect in the &amp;quot;up&amp;quot; and/or &amp;quot;down&amp;quot; buttons of some ACCU-CHEK Spirit insulin pumps. This failure...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/aJyn0WlwDN06hKW_bTkVwX3tzzU/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/aJyn0WlwDN06hKW_bTkVwX3tzzU/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/aJyn0WlwDN06hKW_bTkVwX3tzzU/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/aJyn0WlwDN06hKW_bTkVwX3tzzU/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/vOdMgG-L1Yo" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 01 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/disetronic-medical-systems-inc-accu-chek-spirit-insulin-pump-12515.html</feedburner:origLink></item>

	<item>
		<title>Hydroxycut Products</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/7ZcAPizmLUk/hydroxycut-products-12514.html</link>
		<description>Audience: Consumers, healthcare professionals FDA warned consumers to immediately stop using Hydroxycut products by Iovate Health Sciences, Inc., because they are associated with serious liver injuries. Hydroxycut products are dietary supplements...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/1gY0m4iJTNjT1kc6EZTom3-86_U/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/1gY0m4iJTNjT1kc6EZTom3-86_U/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/1gY0m4iJTNjT1kc6EZTom3-86_U/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/1gY0m4iJTNjT1kc6EZTom3-86_U/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/7ZcAPizmLUk" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 01 May 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/hydroxycut-products-12514.html</feedburner:origLink></item>

	<item>
		<title>Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/zId7iAanzH4/botox-botox-cosmetic-botulinum-toxin-type-myobloc-botulinum-toxin-type-b-12513.html</link>
		<description>Audience: Cosmetic surgeons, neurologists, consumers FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/Nu9Xr1-yNuzcvMB2sxrPDhNkr9s/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Nu9Xr1-yNuzcvMB2sxrPDhNkr9s/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/Nu9Xr1-yNuzcvMB2sxrPDhNkr9s/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Nu9Xr1-yNuzcvMB2sxrPDhNkr9s/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/zId7iAanzH4" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 30 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/botox-botox-cosmetic-botulinum-toxin-type-myobloc-botulinum-toxin-type-b-12513.html</feedburner:origLink></item>

	<item>
		<title>Personal Care Non-Acetone Nail Polish Remover</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/lJIN1IGDDOY/personal-care-non-acetone-nail-polish-remover-12512.html</link>
		<description>Audience: Dermatologists, ER healthcare professionals Personal Care Products and FDA notified healthcare professionals of a voluntary nationwide recall of all lots of Personal Care non-acetone nail polish remover, conditioner enriched with gelatin,...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/VxzxVpKgNX0fz0HIxpGMEChsMkc/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/VxzxVpKgNX0fz0HIxpGMEChsMkc/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/VxzxVpKgNX0fz0HIxpGMEChsMkc/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/VxzxVpKgNX0fz0HIxpGMEChsMkc/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/lJIN1IGDDOY" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 29 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/personal-care-non-acetone-nail-polish-remover-12512.html</feedburner:origLink></item>

	<item>
		<title>Libimax</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/nVov0OoL-XE/libimax-12511.html</link>
		<description>Audience: Consumers, pharmacists Nature &amp;amp; Health Co. and FDA notified healthcare professionals of a recall of a supplement product, Libimax. FDA analysis found the product contains tadalafil, an active ingredient of an FDA-approved drug for...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/6RgkovWVLmL1JZY23MaLmub7hMY/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/6RgkovWVLmL1JZY23MaLmub7hMY/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/6RgkovWVLmL1JZY23MaLmub7hMY/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/6RgkovWVLmL1JZY23MaLmub7hMY/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/nVov0OoL-XE" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 29 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/libimax-12511.html</feedburner:origLink></item>

	<item>
		<title>Dietary Supplements Distributed by Universal ABC Beauty Supply International, Inc.</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/xfn38vddXgo/dietary-supplements-distributed-universal-abc-beauty-supply-international-inc-12510.html</link>
		<description>Audience: Consumers, pharmacists [Posted 04/22/2009] ABC Beauty Supply and FDA notified consumers and healthcare professionals of a recall of 34 dietary supplement products. FDA lab analyses identified undeclared sibutramine, an FDA-approved drug,...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/DjpTOy5azkSGAjr2OxKucXXvJNE/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/DjpTOy5azkSGAjr2OxKucXXvJNE/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/DjpTOy5azkSGAjr2OxKucXXvJNE/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/DjpTOy5azkSGAjr2OxKucXXvJNE/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/xfn38vddXgo" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 22 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/dietary-supplements-distributed-universal-abc-beauty-supply-international-inc-12510.html</feedburner:origLink></item>

	<item>
		<title>Influend Cough and Cold Products</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/r2hKTpaq5Qo/influend-cough-cold-products-12509.html</link>
		<description>Audience: Pharmacists, consumers [Posted 04/16/2009] ION Labs and FDA notified consumers and healthcare professionals of the recall of all Influend Cough and Cold products sold on or after May 30, 2008 due to the possibility that the products may be...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/Ot3YOcjV4e6HKaAWWmCG7S_eaNk/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Ot3YOcjV4e6HKaAWWmCG7S_eaNk/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/Ot3YOcjV4e6HKaAWWmCG7S_eaNk/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Ot3YOcjV4e6HKaAWWmCG7S_eaNk/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/r2hKTpaq5Qo" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 16 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/influend-cough-cold-products-12509.html</feedburner:origLink></item>

	<item>
		<title>Ceftriaxone (marketed as Rocephin and generics)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/UGT7-CIe_60/ceftriaxone-marketed-rocephin-generics-12508.html</link>
		<description>Audience: Neonatology, infectious disease healthcare professionals, hospital risk managers [Posted 04/14/2009] FDA notified healthcare professionals of an update to a previous alert that addresses the interaction of ceftriaxone with...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/IumZgSwbzsH9ukfe-qcAk0Qkdfo/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/IumZgSwbzsH9ukfe-qcAk0Qkdfo/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/IumZgSwbzsH9ukfe-qcAk0Qkdfo/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/IumZgSwbzsH9ukfe-qcAk0Qkdfo/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/UGT7-CIe_60" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 14 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/ceftriaxone-marketed-rocephin-generics-12508.html</feedburner:origLink></item>

	<item>
		<title>Raptiva (efalizumab)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/HHGusFWb0Lg/raptiva-efalizumab-12505.html</link>
		<description>Audience: Dermatological healthcare professionals, patients [UPDATE 04/08/2009] Genentech and FDA notified healthcare professionals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of psoriasis, from the U.S. market due to...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/JGiszsBk9K5lGfchGZ0sZ3mr-w0/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JGiszsBk9K5lGfchGZ0sZ3mr-w0/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/JGiszsBk9K5lGfchGZ0sZ3mr-w0/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JGiszsBk9K5lGfchGZ0sZ3mr-w0/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/HHGusFWb0Lg" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 08 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/raptiva-efalizumab-12505.html</feedburner:origLink></item>

	<item>
		<title>Digoxin, USP 0.125 mg, Digoxin, USP 0.25 mg (Caraco brand)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/-tAnZdPs9yg/digoxin-usp-0-125-mg-digoxin-usp-0-25-mg-caraco-brand-12503.html</link>
		<description>Audience: Pharmacists, cardiology healthcare professionals, consumers [Posted 04/01/2009] Caraco Pharmaceutical Laboratories and FDA notified healthcare professionals of a consumer-level recall of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin,...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/S1EUeWYgM9m9fIEIk2IXztg9oaM/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/S1EUeWYgM9m9fIEIk2IXztg9oaM/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/S1EUeWYgM9m9fIEIk2IXztg9oaM/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/S1EUeWYgM9m9fIEIk2IXztg9oaM/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/-tAnZdPs9yg" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 01 Apr 2009 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/digoxin-usp-0-125-mg-digoxin-usp-0-25-mg-caraco-brand-12503.html</feedburner:origLink></item>
</channel>
</rss>
